NorthWest Biotherapeutics Inc (NWBO)

[QL300]

I think the simplest reason it doesn't have a "wow" factor. Most of the publicity is directed at new trials that are supposed cures for cancer. While some people are cured, this is more like an improvement. Five year survival has more than doubled, it's shown to be effective but survival is still pretty low. I could see some publicity when the combo results with Keytruda come in showing 60%-70%+ survival. Even with MHRA approval, I doubt a lot of media will be covering this.